(STUDY CLOSED) Phase 2 Study of Denosumab (IND#127430, NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma

Submitted by centretek on Sat, 10/15/2022 - 10:29
Source URL
https://www.inova.org/clinical-trials/study-closed-phase-2-study-denosumab-ind127430-nsc-744010-rank-ligand-antibody
Description
General Information Age Group Pediatrics/Children Status Inactive Protocol Number AOST1321 Offered At Inova Children's Hospital 3300 Gallows Road Falls Church, VA 22042 Contact Information Contact Name Keary Jane't Contact Phone 703-776-3456 Contact Email Send Email
Clinical Trials Category
Cancer
Clinical Trials Sub categories
Osteosarcoma
Crawled Content Type
Clinical Trials
Featured Content
Off
Summary
(STUDY CLOSED) Phase 2 Study of Denosumab (IND#127430, NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
Age Group
Pediatrics/Children
Hide in search
Off
is_synonym
Off
Also a children's page
Off